A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
Titel:
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
Auteur:
Mani, Aruna Roda, Julie Young, Donn Caligiuri, Michael A. Fleming, Gini F. Kaufman, Peter Brufsky, Adam Ottman, Susan Carson, William E. Shapiro, Charles L.